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Interaction between renin and the autonomic 
nervous system in hypertension 
The abnormal distribution of plasma renin values described in established essential hypertension 
are also found in patients with very early, borderline hypertension. in established hypertension, 
renin vaiues have been used to draw inferences about the pathophysioiogy of blood pressure 
eievatton. Within this concept, the iow-renin state is considered a volume-dependent (volume 
expanded) form of hypertension. The high-renin state is viewed as high-resistance hypertension 
caused by a renin-dependent vasoconstriction. However, the pathophysioiogy of high- and 
low-renin borderline hypertension does not follow the prediction from the voiume- 
vasoconstrictton theory. The high-renin state is often associated with an increase in cardiac 
output and normal vafues of vascular reststance. Even when the cardiac output is normal and the 
t&i peripheral reeiatance is elevated in high renin, the vasoconstriction is not renin-angiotensin 
dependent. The high-renin borderline and mild hypertension is a state of generalized, increased, 
sympathetic drive to the heart, blood vessels, and kidneys. After the influence of the autonomic 
nervous system is removed by pharmacologic blockade, blood pressure in patients with 
high-renin values becomes normal. To the contrary, pharmacologic antagonization of angiotensin 
ii with a converting enzyme inhibitor does not lead to normal blood pressure values in patients 
with high-renin. Patients with borderline hypertension with low renin have normal plasma and 
blood volume values. However, because of decreased compliance of the peripheral capacitance 
space, the blood volume is shifted from the peripheral to the central (cardiopulmonary) portion of 
the circulation. Expansion of the cardiopulmonary blood volume causes a larger stretch of 
cardiopulmonary mechanoreceptors, which, in turn, elicits a preferential inhibition of the 
sympathetic tone to the kidneys. The low-renin and low sympathetic tone in these patients are 
the consequence of the expansion of the cardiopulmonary blood volume and not of the total 
blood volume. (AM HEART J 196&116:611.) 
Steve Julius, MD, ScD Ann Arbor, Mich. 
John Laragh’s’ classification of hypertension into 
low-, normal-, and high-renin subgroups represents 
a major milestone in contemporary thinking about 
the pathophysiology of hypertension. The concept 
that patients with hypertension are not a homoge- 
neous group and that this heterogenecity may pre- 
dict patient’s responses to various types of antihy- 
pertensive treatment greatly altered our thinking 
about hypertension. The notion that renin levels 
may reflect different underlying pathophysiologic 
processes (e.g., that patients with low-renin values 
have “volume” hypertension and those with high 
renin have “vasoconstrictor” hypertension), al- 
though helpful as a teaching tool, immediately cre- 
ated vigorous reactions, as one might expect with 
any new and creative idea. It was pointed out that 
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although entirely logical, the concept was theoretic 
and that actual hemodynamic measurements do not 
support the notion of volume expansion in low-renin 
hypertension.2 Similarly, it was found that patients 
with very mild hypertension and high-renin values 
have high cardiac output3 and are only “relatively 
vasoconstricted;” that is, their resistance is not 
appropriately dilated to accommodate the increased 
cardiac output.4 
Physiologically, the renin-angiotensin system 
interacts with the autonomic nervous system. A 
/3-adrenergic receptor is involved in the renin release 
from the kidneys; the renin-angiotensin system has 
central nervous system effects; peripherally, angio- 
tensin II potentiates sympathetic responses. 
Over a period of years, we have been interested in 
the role of the nervous system in hypertension, 
particularly in patients with mild and borderline 
hypertension. This review will show that the renin 
classification is also applicable to this early stage of 
hypertension, but that the underlying pathophysiol- 
ogy in these patients does not follow the prediction 
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from the volume-vasoconstriction concept of hyper- 
tension. In low-renin cases the total blood volume is 
normal, but its distribution is abnormal, causing a 
volume expansion in the cardiopulmonary portion of 
the venous capacitance. In high-renin cases 
observed vasoconstriction depends on the enhanced 
sympathetic drive. High renin in these patients does 
not appear to act as a direct vasoconstrictor. 
HIGH-RENIN BORDERLINE AND MILD HYPERTENSION 
Numerous lines of evidence in our laboratory 
pointed toward a strong role for the autonomic 
nervous system in mild and borderline hypertension. 
These results have been reviewed elsewhere.5s6 In 
short, it was shown that the elevation of cardiac 
output is neurogenic and that it is caused by a higher 
sympathetic drive and a lower parasympathetic 
inhibition of the heart. Since two components (sym- 
pathetic and parasympathetic) were abnormal and 
the change in the tone of these two components was 
reciprocal, this suggested that the abnormality ema- 
nates from the medulla oblongata. Integration of 
cardiovascular sympathetic and parasympathetic 
tone does occur in the medulla, and the response 
characteristically is reciprocal; that is, higher tone in 
one is associated with lesser tone in the other branch 
of the autonomic nervous system. Various inputs 
ascend or descend on the medullary cardiovascular 
center and are able to change the peripheral cardio- 
vascular autonomic tone. 
We investigated the possible role of arterial baro- 
receptors in the genesis of this autonomic imbalance 
and found that their sensitivity is not altered in 
patients with hyperkinetic borderline hypertension’ 
Next, we focused on psychosomatic factors as a 
possible cause of the observed hemodynamic and 
autonomic nervous system abnormality. Emotional 
excitement elicits fast heart rates and elevation of 
blood pressure. This has been investigated in ani- 
mals, and it has been shown that induction of the 
“defense reaction” causes a stereotypic circulatory 
response. Brod8 pointed out the similarities between 
the hemodynamic pattern in patients with hyper- 
tension to that of the elicited defense reaction in 
animals. Our patients with borderline hypertension 
show a characteristic personality pattern; they are 
outwardly oriented, submissive to others, but at the 
same time suspicious. s, lo These subjects are also 
prone to “holding in” their anger,” but experience a 
hisher suhiective intensity of anger.12 
Since the autonomic abnormality in borderline 
and mild hypertension appeared to have a central 
nervous system origin and could possibly be associ- 
ated with psychosomatic factors, one would expect 
that the abnormality would be widespread. We 
postulated that conceptually all observed abnormal- 
ities in borderline hypertension (increased venous 
tone, decreased plasma volume, increased vascular 
resistance, larger stroke volume, faster heart rate, 
and high plasma-renin activity levels) could be 
explained by a general increase in the cardiovascular 
autonomic drive.6 Consequently, Esler et all3 
embarked on a systematic investigation of the rela- 
tionship between the sympathetic tone and the 
plasma-renin activity in borderline and mild hyper- 
tension. These studies3p I3 culminated in their report 
in the New England Journal of Medicine on 
patients with mild but established hypertension.12 In 
this study, patients with high renin had normal 
resting cardiac output levels. Nevertheless, when 
they were given intravenous propranolol, they 
responded with both a greater decrease in the 
cardiac index and heart rate and a greater increase 
in the preejection period compared with patients 
with normal-renin values and normotensive control 
subjects. Thus the high-renin state was associated 
with signs of increased cardiac /3-adrenergic drive. 
This pharmacologic evidence for increased sympa- 
thetic drive in patients with high-renin hypertension 
also confirmed by the biochemical observation that 
their plasma norepinephrine level was elevated. 
After cardiac blockade with propranolol and atro- 
pine, blood pressure in these patients with high- 
renin values still remained elevated through a vaso- 
constrictive mechanism (a high vascular resistance). 
This vasoconstriction could have been caused either 
by high-renin levels or by an enhanced a-adrenergic 
drive. This issue was put to the test with the 
cY-adrenergic blockade with phentolamine. After 
phentolamine, blood pressure in patients with high 
renin fell to the normal range. We interpreted this to 
mean that high renin in these patients reflected the 
generalized increase of the sympathetic drive, but 
actual blood pressure maintenance depended on an 
enhanced a-adrenergic arteriolar tone. 
Interestingly, in this study patients with high- 
renin, mild established hypertension had a personal- 
ity structure similar to those with hyperkinetic 
borderline hypertension; for example, they were 
submissive and prone to holding in their anger.12 
Thus high-renin mild hypertension appears to be an 
entirely neurogenic form of human hypertension, 
possibly of psychosomatic origin. 
We also tested the effect of intravenous convert- 
ing-enzyme inhibition with teprotide in a small 
group of patients with high-renin hypertension com- 
pared with patients with normal-renin values. The 
purpose of the study was to investigate directly 
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SQ 20,881 Propranolol Atropine Regitine 
Rest 1 mg/kg 0.2 mglkg 0.04 mglkg 15 mg 
Minutes [3oJTj pJ pJ pi-/ 
Hemodynamics + + + ++ + + + 
Fig. 1. The study design SQ 20881 is teprotide (Squibb), the first angiotensin-converting enzyme 
inhibitor available for human use. It was given as an intravenous infusion. The peptide had a very short 
half-life, and its activity was probably lost 5 minutes after discontinuation of the infusion. 
whether high renin could have been the cause of 
blood pressure elevation in these patients with 
borderline hypertension. Unfortunately, our sup- 
plies of teprotide were limited, and we did not have a 
control group of normotensive subjects. I retrieved 
the data from our files and have found that they 
usefully complement the other studies. 
The design of the study, as shown in Fig. 1, was a 
short-term study of SQ 20881 (teprotide), the first 
converting-enzyme inhibitor available for human 
use. The drug was infused in the recommended 
blocking dose of 1 mg/kg/min. This was then fol- 
lowed by a fast sequence of propranolol, atropine, 
and regitine. As shown in Fig. 2, the five patients 
with high-renin values had mean blood pressures 
similar to the eight patients with low-renin border- 
line hypertension, but the cardiac index of the 
high-renin group was significantly elevated. Thirty 
minutes of teprotide did not alter the hemodynam- 
its or blood pressure levels. After the autonomic 
blockade, cardiac output in patients with high renin 
fell to values comparable to patients with low- 
renin. The autonomic blockade also elicited a fall of 
blood pressure in patients with high renin to a level 
significantly below that of the low-renin group. 
After autonomic blockade, blood pressure in the 
high-renin group fell to the normotensive range. 
However, since blood pressure levels of similarly 
treated normal control subjects are not available, we 
cannot evaluate the significance of this finding. 
Nevertheless, the study permits three conclu- 
sions: (1) It shows the difference between the high- 
and low-renin groups. (2) It proves that antagoniz- 
ing the angiotensin II does not normalize blood 
pressure in these patients. (3) It shows that after 
blockade of angiotensin II, patients with high renin 
still show an excessive cardiac and vascular adrener- 
gic drive. The study is not only in line with our 
previous research on the importance of excessive 
autonomic drive in high-renin hypertension, but it 
also suggests that renin-angiotensin elevation is not 
the primary event. We speculate that a primary 
elevation of angiotensin II is not responsible 
(through its central nervous system action) for the 
higher autonomic tone in high-renin hypertension 
because the higher tone was still present during 
blockade of angiotensin II (cardiac output and blood 
pressure remained elevated during the infusion). 
These experiments strengthen, but do not prove our 
contention that an increase in central nervous sys- 
tem drive is the primary event, and renin elevation 
is only one sign of this generalized increase in 
sympathetic drive. 
LOW-RENIN BORDERLINE HYPERTENSION 
Patients with low-renin borderline hypertension 
studied in our laboratory do not have an increase in 
plasma volume. However, we confirmed our earlier 
observation that the cardiopulmonary blood volume 
is expanded in borderline hypertension.14 In the new 
studies it became clear that redistribution of a 
normal total blood volume from the peripheral to 
the central portion of the capacitance space is 
particularly characteristic of patients with low-renin 
borderline hypertension. l5 It has been noted that in 
addition to large cardiopulmonary blood volume, 
these patients also have suppressed sympathetic 
tone.16 
These findings pointed to two possibilities: (1) 
Some patients with borderline hypertension have a 
restricted peripheral venous capacitance caused by 
either a decrease in venous compliance or an 
increase in the peripheral venous tone. (2) The 
increase in cardiopulmonary blood volume could 
cause a larger stretch of cardiopulmonary mechano- 
receptors, which, in turn, may inhibit the renal 
sympathetic tone and thereby lower the plasma- 
renin values in the upright position. We postulated 
this hypothesis in 1976,16 but it took a long detour 
into the physiologic regulation of renin release in 
normal humans before the hypothesis could be 
tested on patients. 
Animal experiments clearly demonstrated the 
existence of stretch receptors in the heart and large 
pulmonary veins. 17* l8 Stimulation of these receptors 
causes a generalized withdrawal of the sympathetic 
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Fig. 2. Hemodynamic effect after teprotide (SQ 20881) 
and “triple autonomic blockade” with atropine, propano- 
101, and regitine. *p = <0.05 and $ = <O.Ol difference 
between the groups (Student t tests), and 9 denotes 
p < 0.05 by paired comparison within the group. 
MBP = mean blood pressure; CI = cardiac index; 
TPR = total peripheral resistance; PRA = plasma renin 
activity. 
output, but the effect on the renal sympathetic tone 
is most pronounced.3p5T6 It has been shown that 
cardiopulmonary mechanoreceptors mediate renin 
release in anima1s.7-10 Thus based on these animal 
experiments, our hypothesis-that the low-renin 
state in humans may be caused by an excessive 
stretch of cardiopulmonary mechanoreceptors- 
seemed reasonable. Problems came about concern- 
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Fig. 3. Venous volume-pressure curve for normal sub- 
jects (closed circles) and hypertensive subjects (open 
circles). A Calf volume = the change in calf volume 
induced by thigh cti inflation at each distending pres- 
sure. *p < 0.05. 
ing the issue of whether cardiopulmonary mechano- 
receptors function in exactly the same manner in 
human beings as they do in animals. The existence 
of these receptors and their physiologic role in 
humans have been demonstrated,“* l2 but there was 
some doubt regarding whether they regulate renin 
release. The main objection came from a group of 
investigators who used lower body negative pressure 
to cause peripheral venous pooling and a decrease in 
the stretch on cardiopulmonary mechanoreceptors.L4 
Under these circumstances, a small decrease in the 
right atrial pressure did not cause an increase in 
plasma renin. However, an increase was observed 
when the lower body negative pressure was so strong 
that it also induced a fall in the arterial pressure. 
These results suggested that cardiopulmonary 
mechanoreceptors are not involved in the regulation 
of renin release in humans, but that arterial barore- 
ceptors are involved. Since in every other aspect the 
regulation of renin in animals and humans is the 
same, this particular exception was unexpected. We 
began to wonder whether the technique of lower 
body negative pressure induces some artifacts. The 
lower body vacuum suction requires a tight seal at 
the interface between the pressure chamber and the 
body surface. In all such experiments, the chamber 
is sealed at the level of the iliac crest. This, of 
necessity, also includes a part of the lower abdomen. 
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There was ample evidence that this maneuver also 
decreases the intra-abdominal pressure.‘s-22 This 
negative abdominal pressure could be transmitted 
to the kidneys and affect the intrarenal renin- 
regulating baroreceptors. Furthermore, numerous 
circulatory reflexes can be elicited from the richly 
innervated abdominal cavity.23 Consequently, we 
sought a technique that would permit pooling the 
blood in the lower part of the body without affecting 
the pressure in the abdominal cavity. The old tech- 
nique of using a tourniquet to decrease cardiac 
preload has been modified, and various degrees of 
pressure were generated in a pair of narrow inflat- 
able cuffs placed high on the experimental subjects’ 
thighs.24 This caused the expected pooling of blood 
in the legs (the right atrial pressure and the cardio- 
pulmonary blood volume decreased) and an increase 
in renin values. That this increase in renin was reflex 
mediated has been shown in two ways: (1) The 
response could be abolished with /3-adrenergic 
blockade, and (2) patients with transplanted and 
therefore denervated kidneys did not respond to 
thigh cuff inflation with an increase in renin. This 
initial encouraging result lead to a series of experi- 
ments that are well-summarized by Egan et al.26* 26 
Using various maneuvers (positive lower body pres- 
sure, tilting, sitting with legs extended horizontally, 
and various levels of thigh cuff inflation) Egan et al. 
provided ample proof that cardiopulmonary mecha- 
noreceptors exert the predominant role in the reflex 
regulation of renin in human beings. These results 
have recently been confirmed by Mancia et a1.z7 who 
used the lower body negative pressure technique 
and leg raising to explore the full range of the reflex 
activity. They conclude that the cardiopulmonary 
mechanoreceptors can both increase and decrease 
renin from prevailing baseline levels. 
When sufficient evidence that the cardiopulmo- 
nary mechanoreceptors control renin release in 
humans had been collected, we decided to reinvesti- 
gate the original hypothesis that low renin in border- 
iine and mild hypertension might be caused by a 
larger stretch of cardiopulmonary receptors because 
of the expansion of cardiopulmonary blood volume. 
This was studied by Fitzpatrick et al.% Thigh cuff 
inflation was again used to elicit renin responses and 
also to measure the compliance of the veins in the 
legs. Fig. 3 shows that as a group, patients with 
borderline hypertension had less distensible leg 
veins. Fig. 4 illustrates that patients with normal- 
renin values and normotensive control subjects 
pooled a similar amount of blood in the legs in 
contrast to the low-renin responders who accumu- 
lated less blood in the legs. These differences in 
A Calf Volume 
A Stroke Index 
I I I J 
** 
E2 Normal Controls 
Q Normal-Renin Responders 
0 Low-Renin Responders 
Fig. 4. Changes in calf volume and stroke index induced 
by thigh cuff inflation in normal controls, normal-renin 
responders, and low-renin responders. Significant differ- 
ences between the two hypertensive groups are shown by 
symbols over bars connecting each column, and differ- 
ences between either hypertensive group and the normal 
controls are shown on the column for the hypertensive 
group. *p < 0.05; **p < 0.01; ***p < 0.005. 
venous pooling elicited appropriate changes in car- 
diac preload, as shown in Fig. 4 by the differences in 
stroke volume. 
These experiments clearly indicate that low-renin 
values in hypertensive patients are the result of a 
hemodynamic abnormality. Patients with low-renin 
values are not volume expanded in the true sense of 
the word. However, they have abnormally stiff 
peripheral veins, which cause translocation of the 
intravascular fluid toward the central portion of 
circulation. It is very likely that this causes a bigger 
stretch of the cardiopulmonary mechanoreceptors, 
which leads to low-renin and norepinephrine values. 
The possibihty that an excessive cardiac stretch also 
causes a larger release of atria1 natriuretic factors, 
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which may affect renin values, has not yet been 
investigated. 
CONCLUSION 
An abnormal distribution of plasma-renin values 
can already be found in the very early phases of 
hypertension. In these patients the renin values are 
not simple markers for an underlying volume- 
vasoconstriction pathophysiology. The total blood 
volume is not expanded in low-renin hypertension. 
In high-renin cases, the renin elevation is a conse- 
quence of a generalized increase in sympathetic 
tone, but it is not responsible for excessive vasocon- 
striction. The cause of vasoconstriction in these 
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